(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.35%) $0.929
(-1.11%) $10.87
(-0.11%) $0.797
(0.52%) $91.61
0.00% $ 1.470
Live Chart Being Loaded With Signals
Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 0.00 |
Średni wolumen | 4.18M |
Kapitalizacja rynkowa | 0.00 |
EPS | $-0.210 ( 2022-08-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.704 |
ATR14 | $0.0490 (3.33%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-08-12 | Giordano Michael F | Sell | 8 994 | Common Stock, par value $0.0001 |
2022-08-12 | Goldfischer Carl | Sell | 13 060 | Common Stock, par value $0.0001 |
2022-08-12 | Goldfischer Carl | Sell | 8 994 | Common Stock, par value $0.0001 |
2022-08-12 | Goldfischer Carl | Sell | 3 380 951 | Common Stock, par value $0.0001 |
2022-08-12 | Conroy Kevin T | Sell | 53 324 | Common Stock, par value $0.0001 |
INSIDER POWER |
---|
-89.07 |
Last 98 transactions |
Buy: 31 679 726 | Sell: 42 571 145 |
Wolumen Korelacja
Epizyme Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
APOP | 0.959 |
RMRM | 0.951 |
MEIP | 0.933 |
REAL | 0.932 |
PCVX | 0.93 |
NNOX | 0.927 |
TYHT | 0.925 |
CVGI | 0.922 |
JFU | 0.921 |
PRTA | 0.921 |
10 Najbardziej negatywne korelacje | |
---|---|
XMTR | -0.948 |
ASTR | -0.938 |
INFI | -0.922 |
HRZN | -0.922 |
UPLD | -0.921 |
DTEA | -0.92 |
OM | -0.92 |
VNET | -0.916 |
LUNG | -0.914 |
IRWD | -0.913 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Epizyme Inc Korelacja - Waluta/Towar
Epizyme Inc Finanse
Annual | 2021 |
Przychody: | $37.43M |
Zysk brutto: | $26.93M (71.95 %) |
EPS: | $-2.45 |
FY | 2021 |
Przychody: | $37.43M |
Zysk brutto: | $26.93M (71.95 %) |
EPS: | $-2.45 |
FY | 2020 |
Przychody: | $15.76M |
Zysk brutto: | $10.70M (67.85 %) |
EPS: | $-2.29 |
FY | 2019 |
Przychody: | $23.80M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.930 |
Financial Reports:
No articles found.
Epizyme Inc
Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in patients with PARPi-resistant solid tumors, such as castration-resistant prostate cancer, small cell lung cancer, and others. In addition, the company develops Tazemetostat in patients with INI1-negative tumors in adults and pediatrics; PRMT5 inhibitor for patients with solid tumors; and PRMT1 inhibitor. It has collaboration agreements with Roche Molecular Systems, Inc.; Lymphoma Academic Research Organization; Eisai Co. Ltd.; HUTCHMED (China) Limited; and Roche Sequencing Solutions, Inc. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. As of August 11, 2022, Epizyme, Inc. operates as a subsidiary of Ipsen Biopharmaceuticals, Inc..
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej